Jay T. Flatley's most recent trade in Rivian Automotive Inc - Ordinary Shares - Class A was a trade of 17,445 Class A Common Stock done . Disclosure was reported to the exchange on June 22, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rivian Automotive Inc (Class A) | Jay T. Flatley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2026 | 17,445 | 179,515 | - | 0 | Class A Common Stock | |
| Denali Therapeutics Inc | Jay T. Flatley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 19,226 | 19,226 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Jay T. Flatley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 6,408 | 22,628 (0%) | 0% | 0 | Common Stock | |
| Rivian Automotive Inc (Class A) | Jay T. Flatley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 16,812 | 160,820 | - | 0 | Class A Common Stock | |
| Denali Therapeutics Inc | Jay T. Flatley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 18,111 | 18,111 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Jay T. Flatley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 6,037 | 16,220 (0%) | 0% | 0 | Common Stock | |
| Rivian Automotive Inc (Class A) | Jay T. Flatley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 24,224 | 144,008 | - | 0 | Class A Common Stock | |
| Denali Therapeutics Inc | Jay T. Flatley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 17,901 | 17,901 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Jay T. Flatley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 5,967 | 10,183 (0%) | 0% | 0 | Common Stock | |
| Rivian Automotive Inc (Class A) | Jay T. Flatley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 18,208 | 119,784 | - | 0 | Class A Common Stock | |
| Denali Therapeutics Inc | Jay T. Flatley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 12,649 | 12,649 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Jay T. Flatley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 4,216 | 340,529 (0%) | 0% | 0 | Common Stock | |
| Rivian Automotive Inc (Class A) | Jay T. Flatley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 8,960 | 101,576 | - | 0 | Class A Common Stock | |
| Denali Therapeutics Inc | Jay T. Flatley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 17,959 | 17,959 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Jay T. Flatley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 5,986 | 336,313 (0%) | 0% | 0 | Common Stock | |
| Rivian Automotive Inc (Class A) | Jay T. Flatley | Director | Purchase of securities on an exchange or from another person at price $ 29.31 per share. | 26 May 2022 | 40,000 | 92,616 | - | 29.3 | 1,172,400 | Class A Common Stock |
| Rivian Automotive Inc (Class A) | Jay T. Flatley | Director | Purchase of securities on an exchange or from another person at price $ 78.00 per share. | 15 Nov 2021 | 20,000 | 52,616 | - | 78 | 1,560,000 | Class A Common Stock |